RMTI
Rockwell Medical Inc
NASDAQ: RMTI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.88
-2.56% today
Updated 2026-04-30
Market cap
$35.07M
P/E ratio
—
P/S ratio
0.51x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.7
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$3.00
+242.11%
12-Month target
—
—
Intrinsic (DCF)
$8.93
Margin of safety
+88.58%
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $2.21M — positive
+ 88.58% below intrinsic value
Risks
- Thin margins at -7.67%
- Revenue declining -25.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $72.81M | $83.61M | $101.49M | $69.26M | $69.26M |
| Net income | $-18.68M | $-8.44M | $-480000.00 | $-5.31M | $-554000.00 |
| EPS | — | — | — | — | $-0.15 |
| Free cash flow | $-17.21M | $-9.70M | $3.19M | $-1.20M | $2.21M |
| Profit margin | -25.65% | -10.09% | -0.47% | -7.67% | -7.67% |
Peer comparison
Smart narrative
Rockwell Medical Inc trades at $0.88. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $69.26M. with profit margins at -7.67%. Our DCF model estimates intrinsic value at $8.93.
Frequently asked questions
What is Rockwell Medical Inc's stock price?
Rockwell Medical Inc (RMTI) trades at $0.88.
Is Rockwell Medical Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $8.93.
What is the price target of Rockwell Medical Inc (RMTI)?
The analyst target price is $3.00, representing +242.1% upside from the current price of $0.88.
What is the intrinsic value of Rockwell Medical Inc (RMTI)?
Based on our DCF model, intrinsic value is $8.93, a +88.6% margin of safety versus $0.88.
What is Rockwell Medical Inc's revenue?
TTM revenue is $69.26M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.51x
ROE-15.30%
Beta1.71
50D MA$0.93
200D MA$1.07
Shares out0.04B
Float0.04B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—